AU4450489A - The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c - Google Patents
The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase cInfo
- Publication number
- AU4450489A AU4450489A AU44504/89A AU4450489A AU4450489A AU 4450489 A AU4450489 A AU 4450489A AU 44504/89 A AU44504/89 A AU 44504/89A AU 4450489 A AU4450489 A AU 4450489A AU 4450489 A AU4450489 A AU 4450489A
- Authority
- AU
- Australia
- Prior art keywords
- protein kinase
- calmodulin
- inhibitor
- calcium
- ethylenediaminetetraacetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3838068 | 1988-11-10 | ||
DE3838068 | 1988-11-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU4450489A true AU4450489A (en) | 1990-05-17 |
AU617892B2 AU617892B2 (en) | 1991-12-05 |
Family
ID=6366838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU44504/89A Ceased AU617892B2 (en) | 1988-11-10 | 1989-11-09 | The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase II or of protein kinase C |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0368223A3 (en) |
JP (1) | JPH02180818A (en) |
KR (1) | KR900007410A (en) |
CN (1) | CN1042545A (en) |
AU (1) | AU617892B2 (en) |
CA (1) | CA2002637A1 (en) |
DE (1) | DE3937015A1 (en) |
DK (1) | DK560989A (en) |
HU (1) | HU204195B (en) |
PT (1) | PT92281A (en) |
ZA (1) | ZA898553B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4112103C2 (en) * | 1991-02-18 | 1994-07-14 | Matthias Mueller | Use of acetic acid to regulate blood sugar levels |
AU4205597A (en) * | 1996-08-20 | 1998-03-06 | Novartis Ag | Methods for prevention of cellular proliferation and restenosis |
GB9727224D0 (en) * | 1997-12-23 | 1998-02-25 | Nycomed Imaging As | Method |
DE10138912A1 (en) * | 2001-08-08 | 2003-02-27 | Medinnova Ges Med Innovationen | Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances |
HU229104B1 (en) | 2007-11-22 | 2013-07-29 | Pharmateka Bt | Use of edta and its salts for the prevention and treatment of bacterial intestinal swine diseases caused by brachyspira hyodysenteriae and for enhancement of efficiency of antibiotics in curing such illnesses |
EE05628B1 (en) | 2010-12-23 | 2013-02-15 | Tallinna Tehnikaülikool | Composite polymeric material with mineral fillers |
CN111450085A (en) * | 2020-05-22 | 2020-07-28 | 颜廷良 | Broad-spectrum anti-tumor medicine and preparation method and application thereof |
-
1989
- 1989-11-07 DE DE3937015A patent/DE3937015A1/en not_active Withdrawn
- 1989-11-07 EP EP19890120550 patent/EP0368223A3/en not_active Withdrawn
- 1989-11-08 KR KR1019890016138A patent/KR900007410A/en not_active Application Discontinuation
- 1989-11-09 DK DK560989A patent/DK560989A/en not_active Application Discontinuation
- 1989-11-09 JP JP1290165A patent/JPH02180818A/en active Pending
- 1989-11-09 ZA ZA898553A patent/ZA898553B/en unknown
- 1989-11-09 CN CN89108456A patent/CN1042545A/en active Pending
- 1989-11-09 CA CA002002637A patent/CA2002637A1/en not_active Abandoned
- 1989-11-09 AU AU44504/89A patent/AU617892B2/en not_active Ceased
- 1989-11-10 PT PT92281A patent/PT92281A/en not_active Application Discontinuation
- 1989-11-10 HU HU895861A patent/HU204195B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA898553B (en) | 1990-08-29 |
KR900007410A (en) | 1990-06-01 |
AU617892B2 (en) | 1991-12-05 |
DK560989D0 (en) | 1989-11-09 |
JPH02180818A (en) | 1990-07-13 |
PT92281A (en) | 1990-05-31 |
HU204195B (en) | 1991-12-30 |
HUT51893A (en) | 1990-06-28 |
EP0368223A2 (en) | 1990-05-16 |
CA2002637A1 (en) | 1990-05-10 |
EP0368223A3 (en) | 1991-09-25 |
CN1042545A (en) | 1990-05-30 |
DE3937015A1 (en) | 1990-05-17 |
DK560989A (en) | 1990-05-11 |
HU895861D0 (en) | 1990-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH30794A (en) | Inhibition of phosphatidylinositol 3-kinase with worthmannin and analogs thereof. | |
NO890921D0 (en) | PROCEDURE FOR THE PREPARATION OF AMINO ACID DERIVATIVES. | |
NO882200L (en) | PROCEDURE FOR THE PREPARATION OF CALCIUM SULPHATE-ALFA HALIBRATE. | |
SG53193G (en) | Deodorizer for refrigerators of the like | |
AU3482493A (en) | Novel protein tyrosine kinases | |
AU4680797A (en) | Preparation of substituted guanidines | |
AU3731293A (en) | Protein kinase c inhibitor | |
AU1928688A (en) | Tissue factor inhibitor | |
HU893412D0 (en) | Inhibitors of interleucin-1 | |
AU6423590A (en) | The treatment of wood chips | |
AU5102590A (en) | Rapid assay for functional human alpha1-proteinase inhibitor | |
NO881215L (en) | PROCEDURE FOR THE PREPARATION OF ALGES WITH IMPROVED BIOLOGICAL EFFECTS. | |
AU4450489A (en) | The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c | |
FI961378A0 (en) | Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide | |
ITMI931580A0 (en) | PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINS | |
AU1783092A (en) | Inhibitors of protein kinase c function | |
ITMI931680A0 (en) | PROCEDURE FOR THE PREPARATION OF ALKANSULFONAMIDES | |
GB2251402B (en) | Procedure for the manufacture of contour-stable objects | |
AU1122088A (en) | Improvements in the inhibition of lice | |
AU1368888A (en) | Hair growth inhibition using substituted amidines or guanidines | |
IT8822524A0 (en) | PROCEDURE FOR THE PREPARATION OF 6-OXOPENICILLANATES | |
FI960526A (en) | Process for the preparation of cumene hydroperox | |
AU2608588A (en) | Potentiation of antihypertensive effect of ace inhibitors | |
FI945353A (en) | Enzymatic process for the preparation of (S) -6-methoxyl-alpha-methyl-2-naphthaleneacetic acid | |
AU2632088A (en) | Improvements in the inhibition of lice |